GBI Research’s latest report, "Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future" discusses fundamental concepts in biobanking and recent technology advancements in the field. The report also describes ethical and regulatory concerns in biobanking as well as the economic challenges and opportunities surrounding this industry. Furthermore, this report provides strategic recommendations on how to overcome some of the most critical economic, technological and ethical challenges facing this fast-growing sector.
Download Brochure now @ https://marketreportscenter.com/reports/40902/biobanking-developing-smart-sustainable-and-ethically-compliant-biorepositories-for-the-future
Biobanks collect human biospecimens and associated data for medical-scientific research, and organize samples and data in a systematic way for use by others. The importance of biobanks lies in determining the most effective way to store that information and make it available when required. Biobanks may collect different samples from diseased or healthy individuals in various settings. The integration of novel tools such as big data techniques, coupled with the increasing industry need for high-quality biospecimens for research, will lead to expanding biospecimen collections, ultimately resulting in the growth of this sector. Biobanks currently exist on every continent with most located in North America, followed by Europe. Australia has the highest number of biobanks in the Asia-Pacific region whilst India has the highest number of biobanks, when considering the developing economies only.
The development of a biobank depends upon people's willingness to donate their samples for research and to agree to sample storage. The participation and support of the public is therefore of crucial importance as their attitude towards biobanking activities will determine the success of many of these organizations.